Stevanato Group In May Takes Part In Three Major Trade Shows In Europe And North America: Cphi North America (Philadelphia), Pharmapack Europe (Paris) And Interphex NY

Piombino Dese (PD), Italy – In the coming weeks, Stevanato Group will be proactively involved in promoting its drug containment solutions and presenting its integrated portfolio of manufacturing services and automation equipment within the drug delivery systems space.

The Company will take part in three major shows in Europe and the U.S. – CPhI North America, Pharmapack Europe, and Interphex NY – during which visitors can meet our experts and discover the full breadth of Stevanato Group’s offering in terms of integrated capabilities: from high-quality drug containment solutions to device manufacturing, together with inspection systems and assembly equipment.

17 – 19 May 2022 - CPhI North America, Pennsylvania Convention Center, Philadelphia, booth no. 422: our team will be on hand for visitors and customers from North America to present the complete set of analytical services, assembly solutions, drug containment solutions, and contract manufacturing.

18 - 19 May 2022 - Pharmapack Europe, Paris Expo, booths no. B56 and B58: Stevanato Group will take part in the most relevant European trade show for the pharma packaging and drug delivery device industry with its portfolio of services in contract manufacturing and assembly. This year, the Company will be also pleased to present the recent collaboration with Owen Mumford for the innovative Aidaptus® auto-injector.

24 – 26 May 2022 – Interphex, Javits Center, NYC, booth no. 3204: Stevanato Group welcomes visitors and clients in New York with a live demo of a collaborative pilot assembly platform and presents its advanced inspection systems, to help pharma companies from the early stage up to the commercialization.

About Stevanato Group

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. To learn more, visit: www.stevanatogroup.com.

Contacts

Media
Stevanato Group
media@stevanatogroup.com

Investor Relations
Lisa Miles
lisa.miles@stevanatogroup.com